DK0494621T3 - Substitueret alkensyre og derivater deraf - Google Patents

Substitueret alkensyre og derivater deraf

Info

Publication number
DK0494621T3
DK0494621T3 DK92100113.7T DK92100113T DK0494621T3 DK 0494621 T3 DK0494621 T3 DK 0494621T3 DK 92100113 T DK92100113 T DK 92100113T DK 0494621 T3 DK0494621 T3 DK 0494621T3
Authority
DK
Denmark
Prior art keywords
derivatives
alkenoic acid
substituted alkenoic
acid
carboxyphenylthio
Prior art date
Application number
DK92100113.7T
Other languages
Danish (da)
English (en)
Inventor
Heinrich Dr Meier
John E Butler Dr Ransohoff
Trevor Smyth Dr Abram
Peter Dr Norman
Stephen Richard Dr Tudhope
Phillip John Dr Gardiner
Nigel James Dr Cuthbert
Hilary Patricia Dr Francis
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0494621T3 publication Critical patent/DK0494621T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DK92100113.7T 1991-01-10 1992-01-07 Substitueret alkensyre og derivater deraf DK0494621T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919100493A GB9100493D0 (en) 1991-01-10 1991-01-10 Substituted alkenoic acid and its derivatives

Publications (1)

Publication Number Publication Date
DK0494621T3 true DK0494621T3 (da) 1995-12-27

Family

ID=10688219

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92100113.7T DK0494621T3 (da) 1991-01-10 1992-01-07 Substitueret alkensyre og derivater deraf

Country Status (21)

Country Link
US (1) US5246966A (cs)
EP (1) EP0494621B1 (cs)
JP (1) JPH04321663A (cs)
KR (1) KR920014775A (cs)
AT (1) ATE125793T1 (cs)
AU (1) AU643355B2 (cs)
CA (1) CA2058884A1 (cs)
CZ (1) CZ286679B6 (cs)
DE (1) DE69203732T2 (cs)
DK (1) DK0494621T3 (cs)
ES (1) ES2076559T3 (cs)
FI (1) FI920075A7 (cs)
GB (1) GB9100493D0 (cs)
GR (1) GR3017031T3 (cs)
HU (2) HU213475B (cs)
IE (1) IE920073A1 (cs)
IL (1) IL100599A (cs)
MY (1) MY108136A (cs)
PL (2) PL169083B1 (cs)
RU (1) RU2058979C1 (cs)
ZA (1) ZA92142B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523946D0 (en) * 1995-11-23 1996-01-24 Bayer Ag Leukotriene antagonistic benzoic acid derivatives
DE19943634A1 (de) * 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds
GB2218416A (en) * 1988-05-13 1989-11-15 Bayer Ag Leukotriene disease antagonists
ATE96149T1 (de) * 1989-07-27 1993-11-15 Bayer Ag Arylalkensaeurederivate als leukotrienantagonisten.

Also Published As

Publication number Publication date
CS7492A3 (en) 1992-08-12
HU213475B (en) 1997-06-30
HU211553A9 (en) 1995-12-28
DE69203732T2 (de) 1996-01-18
DE69203732D1 (de) 1995-09-07
HU9200090D0 (en) 1992-03-30
JPH04321663A (ja) 1992-11-11
PL169083B1 (pl) 1996-05-31
GR3017031T3 (en) 1995-11-30
IE920073A1 (en) 1992-07-15
FI920075L (fi) 1992-07-11
RU2058979C1 (ru) 1996-04-27
KR920014775A (ko) 1992-08-25
US5246966A (en) 1993-09-21
MY108136A (en) 1996-08-15
CZ286679B6 (cs) 2000-06-14
EP0494621A1 (en) 1992-07-15
CA2058884A1 (en) 1992-07-11
FI920075A0 (fi) 1992-01-08
HUT60469A (en) 1992-09-28
PL293117A1 (en) 1992-12-28
AU1012292A (en) 1992-07-16
AU643355B2 (en) 1993-11-11
ATE125793T1 (de) 1995-08-15
GB9100493D0 (en) 1991-02-20
ZA92142B (en) 1992-09-30
EP0494621B1 (en) 1995-08-02
FI920075A7 (fi) 1992-07-11
PL168848B1 (pl) 1996-04-30
IL100599A0 (en) 1992-09-06
ES2076559T3 (es) 1995-11-01
IL100599A (en) 1997-02-18

Similar Documents

Publication Publication Date Title
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
ATE269290T1 (de) Benzoylderivate
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
ES2056783T3 (es) Derivados sustituidos del acido benzoico con actividad cardiovascular.
MX9204029A (es) Procedimiento de preparacion de un derivado de la bacatina iii y de la 10-desacetil bacatina iii
ATE147386T1 (de) Kondensierte pyrimidinderivate, ihre herstellung und ihre verwendung als antitumormittel
PT86785A (pt) Novel naphthalene derivatives having use as antiallergy and antiinflammatory agents
DK160098C (da) Tricycliske oxindolcarboxamid-derivater
DE69514284D1 (de) Herstellung von Catechol-Estrogen-Derivaten
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
DK0494621T3 (da) Substitueret alkensyre og derivater deraf
ATE29024T1 (de) Bicyclooctanderivate, ihre herstellung und ihre verwendung.
IT1251202B (it) 6-amminochinoloni, sintesi ed impiego come antibatterici
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
DK0389162T3 (da) 2,5,6,7-Tetranor-4,8-inter-m-phenylen PGI2 derivater
GR900100356A (el) Νέα παράγωγα 9α-υδροξυ-3-οξο4,24(25)-στιγμασταδιέν-26-οϊκού οξέος και μέ?οδος για την παρασκευή τους.
PL297368A1 (en) Novel derivatives of 2h-benzo (b) pyrane substituted with aryl or n-heteroaryl at position 4, method of obtaining them and their applications as well as preparation containing these compounds
DE68909025D1 (de) Mittel zur Verhinderung von Zahnbelagbildung.
IT1217950B (it) Sali di (r,s) 3 (4 fenil 1 piperazinil) 1,2 propandtolo
ES2053808T3 (es) Nuevos compuestos azolicos.
FI955680A0 (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
SU1783778A1 (ru) Производные 4-(1-окси-1-аминокарбонил-2,2,2-трифторэтил)-n-этиланилинов, обладающие антидотной активностью к хлорсульфурону
ITMI913075A0 (it) Derivati dell'acido 2,6-naftalendicarbossilico 4-sostituito
ATE107923T1 (de) 1,2-dihalogenazolylethanderivate und diese enthaltende pflanzenschutzmittel.
NO922638D0 (no) Anvendelse av 9,12,15-oktadecatrien-6-ynsyre